Parenterals and Injectables

Vetter Starts Operations in Its Center for Visual Inspection and Logistics

January 25, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

Vetter expanded visual inspection facilities and controlled-temperature storage at its Ravensburg Vetter West facility in Germany.

Advances in Delivering Protein and Peptide Therapeutics

November 02, 2016

A variety of strategies have been employed to deliver proteins and peptides in improved parenteral formulations and/or via noninvasive routes.

PTSM: Pharmaceutical Technology Sourcing and Management

Looking for a Root Cause of Parenteral Contaminants

October 05, 2016

Multiple inspection techniques facilitate the identification of particulate matter in vials as part of root-cause investigations and safety evaluations.

Protecting Parenterals in Primary Packaging

October 02, 2016

Primary packaging and manufacturing technologies minimize product/package interaction, protect quality, support safe travel through the supply chain, and enhance performance at point of use.

Aptar Stelmi Presents Alternative Coated Stopper for Sensitive Drugs

September 22, 2016

Aptar Stelmi will present PremiumCoat, an alternative coated stopper for sensitive drugs, at CPhI 2016.

Taking a Closer Look at Parenteral Contaminants

September 02, 2016

Visual inspection of parenteral vials is the first step in a root cause investigation.

Parenteral Advisory: Outmoded Fill/Finish Technology

September 01, 2016

Improvements to aseptic manufacturing procedures are long overdue. But how feasible is it for manufacturers to modernize fill lines of legacy products?

PDA Issues Call to Action for Faster Postapproval Changes

August 29, 2016

The Parenteral Drug Association develops program to address barriers to implementation of postapproval changes.

Recipharm Expands Lyophilization Capacity in Italy

August 25, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

Recipharm is investing EUR3.7 million (approximately $4.18 million) to increase lyophilization capacity at its Masate facility in Italy.

Debating the Role of RABS and Isolators in Aseptic Manufacturing

August 01, 2016

While isolators may offer advantages in high-speed commercial manufacturing lines, RABS continues to be a flexible alternative solution for small-scale production of drugs for clinical use.